Recombinant human TGF beta 2 protein (Active)
- Premium Bioactive
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Recombinant human TGF beta 2 protein (Active) is a Human Full Length protein, in the 21 to 414 aa range, expressed in HEK 293 cells, with >95%, <0.005 EU/µg endotoxin level, suitable for SDS-PAGE, FuncS, Mass Spec, HPLC, Cell Culture.
View Alternative Names
Transforming growth factor beta-2 proprotein, Cetermin, Glioblastoma-derived T-cell suppressor factor, G-TSF, TGFB2
- Mass Spec
Supplier Data
Mass Spectrometry - Recombinant human TGF beta 2 protein (Active) (AB277760)
Mass determination by ESI TOF.
Predicted mass is 45592.13 Da (+/- 1-Da by ESI TOF). Multiple peaks are due to proteolytic cleavage during expression. Peak1 (12720 Da, aa303-414); Peak 2 (32170 DA,aa 21-297; Peak 3 (45592 Da, aa 21-414).
- FuncS
Supplier Data
Functional Studies - Recombinant human TGF beta 2 protein (Active) (AB277760)
Fully biologically active determoned by the dose-dependent inhibition of IL-4 dependent HT-2 cell proliferation.
Cell based assay testing is performed on the first lot of protein only and is provided as a reference for protein activity; subsequent lots of protein must pass all biophysical quality control parameters that meet the same parameters as the first lot.
Lot : GR3373524-1
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant human TGF beta 2 protein (Active) (AB277760)
SDS-PAGE analysis of ab277760.
- HPLC
Supplier Data
HPLC - Recombinant human TGF beta 2 protein (Active) (AB277760)
HPLC analysis of ab277760.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Specifications
Form
Lyophilized
Additional notes
=95% by HPLC
General info
Function
Transforming growth factor beta-2 proprotein. Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-2 (TGF-beta-2) chains, which constitute the regulatory and active subunit of TGF-beta-2, respectively.. Latency-associated peptide. Required to maintain the Transforming growth factor beta-2 (TGF-beta-2) chain in a latent state during storage in extracellular matrix (By similarity). Associates non-covalently with TGF-beta-2 and regulates its activation via interaction with 'milieu molecules', such as LTBP1 and LRRC32/GARP, that control activation of TGF-beta-2 (By similarity).. Transforming growth factor beta-2. Multifunctional protein that regulates various processes such as angiogenesis and heart development (PubMed : 22772368, PubMed : 22772371). Activation into mature form follows different steps : following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-2 (TGF-beta-2) chains remain non-covalently linked rendering TGF-beta-2 inactive during storage in extracellular matrix (By similarity). At the same time, LAP chain interacts with 'milieu molecules', such as LTBP1 and LRRC32/GARP, that control activation of TGF-beta-2 and maintain it in a latent state during storage in extracellular milieus (By similarity). Once activated following release of LAP, TGF-beta-2 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (By similarity).
Sequence similarities
Belongs to the TGF-beta family.
Post-translational modifications
Transforming growth factor beta-2 proprotein. The precursor proprotein is cleaved in the Golgi apparatus to form Transforming growth factor beta-2 (TGF-beta-2) and Latency-associated peptide (LAP) chains, which remain non-covalently linked, rendering TGF-beta-2 inactive.
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Bioengineered 12:4374-4384 PubMed34304709
2021
Applications
FuncS
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com